loading page

A BILATERAL SYNCHRONOUS PRIMARY NON-SMALL CELL LUNG CANCER PATIENT WITH TWO DIFFERENT EGFR MUTATIONS
  • +4
  • Thanh-Dung Quach,
  • Kien Do,
  • Dinh-Tung Nguyen,
  • Gyu Yi,
  • Trang Nguyen Le,
  • Thi-Phuong Vu,
  • Son Hai Vu
Thanh-Dung Quach
Vinmec Times City International Hospital

Corresponding Author:[email protected]

Author Profile
Kien Do
Vietnam National Cancer Hospital
Author Profile
Dinh-Tung Nguyen
VinUniversity
Author Profile
Gyu Yi
Vinmec Times City International Hospital
Author Profile
Trang Nguyen Le
Vinmec Times City International Hospital
Author Profile
Thi-Phuong Vu
Vinmec Times City International Hospital
Author Profile
Son Hai Vu
Vinmec International Health Care System
Author Profile

Abstract

Background: Non-small cell lung cancer (NSCLC) accounts for the majority of all lung cancer cases. Causes of NSCLC are typically identified through molecular testing for EGFR and other mutations. Around half of Asian patients with NSCLC, particularly non-smoking women, have EGFR mutations. Most patients with ipsilateral NSCLC typically have a single common EGFR mutation in exons 18-21. It is extremely rare for patients with bilateral primary NSCLC to harbor two different EGFR mutations. Case summary: We present a 70-year-old non-smoking Vietnamese patient diagnosed with early bilateral primary NSCLC with the presence of EGFR in both exon 18 and exon 19. The complexities of diagnosis and treatment for this case resulted in surgical intervention on the left lung and targeted therapy with afatinib for the right lung. Progression arrest was observered in a period of 12 months. Conclusion: This case highlights a rare instance of synchronous bilateral NSCLC in a non-smoking, 70-year-old Vietnamese woman with complex management, underscoring the challenges of treating synchronous primary tumors with different genetic profiles.
31 Oct 2024Submitted to Cancer Reports
04 Nov 2024Submission Checks Completed
04 Nov 2024Assigned to Editor
04 Nov 2024Review(s) Completed, Editorial Evaluation Pending
07 Nov 2024Reviewer(s) Assigned